This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;90(1):33-39.
doi: 10.4269/ajtmh.13-0150. Epub 2013 Nov 11.

Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya

Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya

Yolanda K Mueller et al. Am J Trop Med Hyg. 2014 Jan.

Abstract

Between 2000 and 2010, Médecins Sans Frontières diagnosed and treated 4,831 patients with visceral leishmaniasis (VL) in the Pokot region straddling the border between Uganda and Kenya. A retrospective analysis of routinely collected clinical data showed no marked seasonal or annual fluctuations. Males between 5 and 14 years of age were the most affected group. Marked splenomegaly and anemia were striking features. An rK39 antigen-based rapid diagnostic test was evaluated and found sufficiently accurate to replace the direct agglutination test and spleen aspiration as the first-line diagnostic procedure. The case-fatality rate with sodium stibogluconate as first-line treatment was low. The VL relapses were rare and often diagnosed more than 6 months post-treatment. Post-kala-azar dermal leishmaniasis was rare but likely to be underdiagnosed. The epidemiological and clinical features of VL in the Pokot area differed markedly from VL in Sudan, the main endemic focus in Africa.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(Top) Admissions for primary visceral leishmaniasis to Amudat and Kacheliba Treatment Centers, Pokot area, Uganda and Kenya. (Bottom) Monthly admissions, by year, from January 2000 to December 2010.
Figure 2.
Figure 2.
Map of number of primary visceral leishmaniasis cases treated between 2000 and 2010 in Amudat and Kacheliba Treatment Centers, per village of residence. (a total of 4,216 cases with Global Positioning System [GPS] locations out of 4,582 cases; 137 cases from Baringo District are outside the map area).
Figure 3.
Figure 3.
Diagnostic algorithm of visceral leishmaniasis used by Médecins Sans Frontières since March 2005 at Amudat and Kacheliba Treatment Centers, Pokot area, Uganda and Kenya.

References

    1. World Health Organization . Control of the Leishmaniases. WHO Technical Report Series; no. 949; 2010. Report of a meeting of the WHO Expert Committee on Control of Leishmaniases, Geneva, 22–26 March 2010. - PubMed
    1. Elnaiem DA. Ecology and control of the sand fly vectors of Leishmania donovani in East Africa, with special emphasis on Phlebotomus orientalis. J Vector Ecol. 2011;36:S23–S31. - PubMed
    1. Gebre-Michael T, Malone JB, Balkew M, Ali A, Berhe N, Hailu A, Herzi AA. Mapping the potential distribution of Phlebotomus martini and P. orientalis (Diptera: Psychodidae), vectors of kala-azar in East Africa by use of geographic information systems. Acta Trop. 2004;90:73–86. - PubMed
    1. Jamjoom MB, Ashford RW, Bates PA, Chance ML, Kemp SJ, Watts PC, Noyes HA. Leishmania donovani is the only cause of visceral leishmaniasis in East Africa; previous descriptions of L. infantum and "L. archibaldi" from this region are a consequence of convergent evolution in the isoenzyme data. Parasitology. 2004;129:399–409. - PubMed
    1. Fendall NR. The spread of kala-azar in Kenya. East Afr Med J. 1961;38:417–419. - PubMed

Publication types

MeSH terms

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /